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Abstract: We report the case of a 49-year-old woman with a prior
history of breast cancer who presented with a subacute course of
progressive dyspnoea, culminating in cardiovascular collapse from
acute right heart failure. D-dimer serum level was elevated. While a
computed tomography of the chest was negative for pulmonary
embolism, the autopsy study revealed multiple carcinomatous em-
boli in distal pulmonary arteries, veins, and lymphatics. Pulmonary
tumor embolism may be more frequent than previously thought, and
could be mistaken for pulmonary thrombo-embolism.
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CASE REPORT
The patient was a 49-year-old woman with a history ofbreast cancer diagnosed 4 years earlier, which was treated
by lumpectomy with axillary lymph node resection, adjuvant
radiotherapy, and chemotherapy, achieving complete clinical
remission. She presented with several weeks of dry cough
and exertional dyspnoea. On physical examination, the pa-
tient was afebrile, with a respiratory rate of 25/min, a blood
pressure of 110/70 mmHg, and a pulse rate of 120/min. There
was jugular venous distention, without peripheral edemas.
Laboratory results showed thrombocytopenia and an elevated
D-dimer serum level (10.000 g/L, normal 500 g/L). An
electrocardiogram demonstrated sinus tachycardia. A chest
computed tomography was negative for pulmonary embolism
and the only abnormal finding was a slight right upper lobe
infiltrate. Transthoracic echocardiography revealed pulmo-
nary hypertension (systolic pressure in the pulmonary artery
70 mmHg) and dilated right heart chambers. The patient’s
clinical condition worsened, with hemodynamic instability
prompting admission to the intensive care unit for hemody-
namic support. Pulmonary artery catheterization performed
under continuous epinephrin perfusion revealed pulmonary
artery pressures of 80/47 mmHg (mean 58 mmHg), a pulmo-
nary capillary wedge pressure of 14 mmHg and a cardiac
index of 1.1 L/min/m2. The patient’s clinical condition wors-
ened despite aggressive hemodynamic support and she died
10 hours after admission to the intensive care unit and 1 week
after she first consulted her general physician.
A complete autopsy was carried out, with family con-
sent. At macroscopy, lungs displayed bilateral metastases
with pleural carcinomatous lymphangitis and dissection of
the main arteries showed no thromboemboli. Carinal and
peribronchial lymph nodes contained metastatic breast can-
cer. Right heart hypertrophy (thickness 0.7 cm) with dilata-
tion was seen at heart examination. At histology, the lungs
showed carcinomatous thromboemboli in distal pulmonary
arteries, veins, and lymphatics, characterized by clusters of
cohesive atypical epithelial cells surrounded by an organizing
thrombus with and without luminal occlusion (Figure 1) and
compatible with a breast origin. Intraparenchymatous pulmo-
nary metastases were observed with glandular differentia-
tion, foci of necrosis and microcalcifications, all typical for
an adenocarcinoma. Uninvolved arteries showed concen-
tric medial hypertrophy as typically observed in pulmo-
nary hypertension.
DISCUSSION
Pulmonary tumor emboli are categorized into large,
proximal emboli, and smaller emboli in the microvasculature.
Although most authors consider pulmonary tumor embolism
(PTE) as a rare disease, autopsy series reveal its presence in
up to 26% of patients dying from cancer.1 Malignancies of
the breast, stomach, lung, and liver are most commonly
associated with PTE.2 Clinical presentation is generally dom-
inated by subacute and progressive dyspnoea with hypoxemia
and tachycardia, but its course may also be acute. PTE and
pulmonary thromboembolism are clinically almost indistin-
guishable, and PTE is often mistaken for thromboembolism.
To our knowledge, very high levels of D-dimer have only
been rarely reported in the setting of PTE. Although this test
is usually used for its high sensitivity at low cutoff values to
rule out pulmonary thromboembolism,3 higher levels are
thought to be more specific for this disease and were mis-
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leading in our case. The elevation of D-dimer concentration is
most probably explained by activation of the coagulation
cascade due to accompanying pulmonary thrombi, and by the
underlying neoplastic disease. Chest radiograph and com-
puted tomography are usually unremarkable in PTE, unless
there is concomitant carcinomatous lymphangitis. Ventila-
tion-perfusion lung scans may be useful, usually demonstrat-
ing multiple distal perfusion defects.2 Pulmonary microvas-
cular cytology obtained by right heart catherization has been
found useful in diagnosing carcinomatous lymphangitis4;
several authors have also reported its usefulness in PTE
without lymphatic involvement. For a definitive diagnosis,
surgical open lung biopsy should be obtained. However,
aggressiveness for making an accurate diagnosis should be
balanced with the almost ineluctably grim outcome of PTE.
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FIGURE 1. Lung histology revealing carcinomatous emboli
due to breast cancer (arrows) in the small pulmonary arteries
(Haematoxylin and Eosin stain, 10).
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